BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 14702637)

  • 21. Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3.
    Naski MC; Colvin JS; Coffin JD; Ornitz DM
    Development; 1998 Dec; 125(24):4977-88. PubMed ID: 9811582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed bone age due to a dual effect of FGFR3 mutation in Achondroplasia.
    Pannier S; Mugniery E; Jonquoy A; Benoist-Lasselin C; Odent T; Jais JP; Munnich A; Legeai-Mallet L
    Bone; 2010 Nov; 47(5):905-15. PubMed ID: 20673820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential regulation of endochondral bone growth and joint development by FGFR1 and FGFR3 tyrosine kinase domains.
    Wang Q; Green RP; Zhao G; Ornitz DM
    Development; 2001 Oct; 128(19):3867-76. PubMed ID: 11585811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-type natriuretic peptide plasma levels are elevated in subjects with achondroplasia, hypochondroplasia, and thanatophoric dysplasia.
    Olney RC; Prickett TC; Espiner EA; Mackenzie WG; Duker AL; Ditro C; Zabel B; Hasegawa T; Kitoh H; Aylsworth AS; Bober MB
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E355-9. PubMed ID: 25387261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular basis for the treatment of achondroplasia.
    Yamanaka Y; Ueda K; Seino Y; Tanaka H
    Horm Res; 2003; 60 Suppl 3():60-4. PubMed ID: 14671399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of FGFR3 with the G380R achondroplasia mutation inhibits proliferation and maturation of CFK2 chondrocytic cells.
    Henderson JE; Naski MC; Aarts MM; Wang D; Cheng L; Goltzman D; Ornitz DM
    J Bone Miner Res; 2000 Jan; 15(1):155-65. PubMed ID: 10646125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell responses to FGFR3 signalling: growth, differentiation and apoptosis.
    L'Hôte CG; Knowles MA
    Exp Cell Res; 2005 Apr; 304(2):417-31. PubMed ID: 15748888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3(G380R) transgenic mice.
    Segev O; Chumakov I; Nevo Z; Givol D; Madar-Shapiro L; Sheinin Y; Weinreb M; Yayon A
    Hum Mol Genet; 2000 Jan; 9(2):249-58. PubMed ID: 10607835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TransCon CNP, a Sustained-Release C-Type Natriuretic Peptide Prodrug, a Potentially Safe and Efficacious New Therapeutic Modality for the Treatment of Comorbidities Associated with Fibroblast Growth Factor Receptor 3-Related Skeletal Dysplasias.
    Breinholt VM; Rasmussen CE; Mygind PH; Kjelgaard-Hansen M; Faltinger F; Bernhard A; Zettler J; Hersel U
    J Pharmacol Exp Ther; 2019 Sep; 370(3):459-471. PubMed ID: 31235532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-type Natriuretic Peptide-induced PKA Activation Promotes Endochondral Bone Formation in Hypertrophic Chondrocytes.
    Hirota K; Hirashima T; Horikawa K; Yasoda A; Matsuda M
    Endocrinology; 2022 Mar; 163(3):. PubMed ID: 35041746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway.
    Matsushita T; Wilcox WR; Chan YY; Kawanami A; Bükülmez H; Balmes G; Krejci P; Mekikian PB; Otani K; Yamaura I; Warman ML; Givol D; Murakami S
    Hum Mol Genet; 2009 Jan; 18(2):227-40. PubMed ID: 18923003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia.
    Lorget F; Kaci N; Peng J; Benoist-Lasselin C; Mugniery E; Oppeneer T; Wendt DJ; Bell SM; Bullens S; Bunting S; Tsuruda LS; O'Neill CA; Di Rocco F; Munnich A; Legeai-Mallet L
    Am J Hum Genet; 2012 Dec; 91(6):1108-14. PubMed ID: 23200862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia.
    Webster MK; Donoghue DJ
    EMBO J; 1996 Feb; 15(3):520-7. PubMed ID: 8599935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of fibroblast growth factor receptor 3 by fibroblast growth factor 2 in cultured chick embryo chondrocytes.
    Suh JY; Kim YS; Park JW; Sonn JK; Kim WT
    Cell Biol Int; 2005 Mar; 29(3):203-12. PubMed ID: 15878293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of PPADS on achondroplasic chondrocytes: inhibition of FGF receptor type 3 over-activity.
    Guzmán-Aránguez A; Crooke A; Yayon A; Pintor J
    Eur J Pharmacol; 2008 Apr; 584(1):72-7. PubMed ID: 18336810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parathyroid hormone receptor type 1/Indian hedgehog expression is preserved in the growth plate of human fetuses affected with fibroblast growth factor receptor type 3 activating mutations.
    Cormier S; Delezoide AL; Benoist-Lasselin C; Legeai-Mallet L; Bonaventure J; Silve C
    Am J Pathol; 2002 Oct; 161(4):1325-35. PubMed ID: 12368206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Local CNP/GC-B system in growth plate is responsible for physiological endochondral bone growth.
    Nakao K; Osawa K; Yasoda A; Yamanaka S; Fujii T; Kondo E; Koyama N; Kanamoto N; Miura M; Kuwahara K; Akiyama H; Bessho K; Nakao K
    Sci Rep; 2015 May; 5():10554. PubMed ID: 26014585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging.
    Kaneki H; Kurokawa M; Ide H
    J Cell Biochem; 2008 Feb; 103(3):753-64. PubMed ID: 17562543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutral endopeptidase-resistant C-type natriuretic peptide variant represents a new therapeutic approach for treatment of fibroblast growth factor receptor 3-related dwarfism.
    Wendt DJ; Dvorak-Ewell M; Bullens S; Lorget F; Bell SM; Peng J; Castillo S; Aoyagi-Scharber M; O'Neill CA; Krejci P; Wilcox WR; Rimoin DL; Bunting S
    J Pharmacol Exp Ther; 2015 Apr; 353(1):132-49. PubMed ID: 25650377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation.
    Dailey L; Laplantine E; Priore R; Basilico C
    J Cell Biol; 2003 Jun; 161(6):1053-66. PubMed ID: 12821644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.